Evaluation of the Rimonabant Impact on the Regression of Asymptomatic Damage Caused by Cardiovascular Risk Factors

Clinical trial NCT00458081 · TERMINATED

Trial details

NCT number: NCT00458081
Sponsor: Sanofi
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Obesity Microalbuminuria Diabetes Mellitus, Type 2 Dyslipidemia

Start date: 2007-03-01
Primary completion: 2009-01-01
Enrollment: 174

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.